326 related articles for article (PubMed ID: 21547541)
1. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.
Guthrie R
Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541
[TBL] [Abstract][Full Text] [Related]
2. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
3. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
4. MATCH results: implications for the internist.
Lutsep HL
Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
6. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
7. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Hankey GJ; Eikelboom JW
Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
[TBL] [Abstract][Full Text] [Related]
8. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
Gorelick P; Sechenova O; Hennekens CH
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
[TBL] [Abstract][Full Text] [Related]
9. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis.
Shah H; Gondek K
Clin Ther; 2000 Mar; 22(3):362-70; discussion 360-1. PubMed ID: 10963290
[TBL] [Abstract][Full Text] [Related]
10. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
11. Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist.
Fisher M
Arch Neurol; 2006 Jan; 63(1):20-4. PubMed ID: 16401733
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
Ahmed N; Coffey JB; Oh R
J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectives.
Bezerra DC; Bogousslavsky J
Cerebrovasc Dis; 2005; 20 Suppl 2():109-18. PubMed ID: 16327260
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of dual antiplatelet therapy in cerebrovascular disease as demonstrated by a decline in microembolic signals. A report of eight cases.
Esagunde RU; Wong KS; Lee MP; Gan HY; Wong MC; Chang HM; Chen CL
Cerebrovasc Dis; 2006; 21(4):242-6. PubMed ID: 16446537
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy.
Habib GB
Clin Cardiol; 2006 Jun; 29(6):244-8. PubMed ID: 16796073
[TBL] [Abstract][Full Text] [Related]
19. Dose titration to reduce dipyridamole-related headache.
Chang YJ; Ryu SJ; Lee TH
Cerebrovasc Dis; 2006; 22(4):258-62. PubMed ID: 16788299
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet drugs in ischemic stroke prevention: from monotherapy to combined treatment.
Urbano LA; Bogousslavsky J
Cerebrovasc Dis; 2004; 17 Suppl 1():74-80. PubMed ID: 14694284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
